Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease

By sjmartinez • April 28, 2023

Rastogi A, Januzzi JL Jr. Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease. J Clin Med. 2023 Apr 12;12(8):2824. doi: 10.3390/jcm12082824. PMID: 37109162.

Tags: cardiac remodeling, cardiovascular outcomes, Chronic kidney disease, glomerular pressure, heart failure, mechanism of action, Nephrology, Publications, renal outcomes, sodium-glucose cotransporter-2 inhibitors, sympathetic nervous system, Type 2 diabetes

Intravitreal vascular endothelial growth factor inhibitor systemic and renal toxicity registry

Nguyen MD, Fekrat R, Gee C, Demirci AN, Kharabaf S, Le D, Tadros M, Nguyen VQ, Patel S, Truong T, Ahdoot R, Kurtz IB, Kerr[...]

Management recommendations for kidney transplantation in patients with plasma cell dyscrasia

Murakami N, Blosser CD, Webber AB, Gupta G, Singh N, Boppana S, Master S, Parasuraman R, Campagnaro EL, Java A, Sprangers B, Bhasin-Chhabra B, Lum[...]

Experiences and perspectives of patients and their caregivers on gastrointestinal symptoms in peritoneal dialysis: Workshop report

Hayat A, Johnson DW, Manera K, Viecelli AK, Wilkie M, Shen J, Wang AY, Htay H, Jaure A, Cho Y, Walker R. Experiences and perspectives[...]